PTP Pentixapharm Holding AG

2.046USD1.865 EUR · XETRA-0.27%Mkt Cap: 73.24M USDP/E: —

Pentixapharm Holding AG, a clinical-stage biopharmaceutical company, develops radiopharmaceuticals. The company focuses on developing CXCR4 binding, peptide-based technology, which includes PentixaFor (PT-001), a tracer …

Institutional holders10 on file

Key Statistics

Company
Market Cap73.24M USD
Enterprise Value46.89M USD
Revenue (TTM)265.43K USD
Gross Profit-7.35M USD
Net Income (TTM)-18.11M USD
Revenue/Share0.01 USD
Last Price2.046 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees38
CountryDE
SectorHealthcare
IndustryBiotechnology
ISINDE000A40AEG0
Valuation
P/E (Trailing)—
P/E (Forward)-2.83
PEG—
EV/EBITDA-2.43
EV/Revenue176.65
P/S275.92
P/B1.32
EPS (TTM)-0.63 USD
EPS (Forward)-0.72 USD
52W Range
1.42624% of range4.058
52W High4.058 USD
52W Low1.426 USD
Profitability
Gross Margin-7207.53%
Oper. Margin-7356.61%
EBITDA Margin0.00%
Profit Margin-17753.76%
ROE-47.08%
ROA-39.44%
ROIC—
ROCE-51.00%
Growth
Revenue Growth-91.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-19.71M USD
CapEx (TTM)685.50K USD
FCF Margin-4078.62%
FCF Yield-14.78%
Net Debt-3.94M USD
Net Debt/EBITDA0.20
Net Debt/FCF—
Balance Sheet
Debt/Equity—
Current Ratio1.55
Quick Ratio1.26
Book Value/Sh1.55 USD
Cash/Share0.16 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)10.26 USD
Upside (mean)+401.6%
Target Range7.897 USD – 12.62 USD
7.897+401.6% to mean12.62
# Analysts2
Ownership
Shares Out.35.80M
Float18.09M
Insiders30.99%
Institutions6.32%
Technical
SMA 502.012 (+1.7%)
SMA 2002.202 (-7.1%)
Beta1.49
S&P 52W Chg12.00%
Avg Vol (30d)8.44K
Avg Vol (10d)11.93K
Technical Indicators
RSI (14)52.3
MACD0.0066
MACD Signal-0.0073
MACD Hist.+0.0139
BB Upper2.197 USD
BB Middle1.988 USD
BB Lower1.779 USD
BB Width21.04%
ATR (14)0.0857 USD
Vol Ratio (20d)0.47x

About Pentixapharm Holding (ETR: PTP)

›

Pentixapharm Holding (ETR: PTP) is listed on Xetra (Frankfurt), where its shares trade in EUR. It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 38 employees.

The shares were at 1.865 EUR on 19 November 2026, up 11.9% over 52 weeks. Its 52-week range is 1.300 EUR to 3.700 EUR: the price is 49.6% below the high and 43.5% above the low.

Its market capitalisation is 66.77M EUR.

Pentixapharm Holding reports return on equity of -47.1% and revenue down 91.2% year over year.

It holds more cash than debt, a net cash position of 3.59M EUR. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health.